China's Shenyang expands nucleic acid testing to stem new COVID-19 cases
SHENYANG -- Shenyang, capital of northeast China's Liaoning province, has expanded the scope of nucleic acid testing following new cases of COVID-19, said local health authorities.
On Tuesday afternoon, Shenyang launched nucleic acid testing for residents of more areas in the four districts where a total of four locally transmitted COVID-19 cases had been reported so far.
The testing is expected to be completed on Thursday, according to the authorities.
The province was hit by a new round of coronavirus infections on Friday, following which nucleic acid testing was immediately launched in key areas of Shenyang and the city of Yingkou.
On Monday, Liaoning reported four new confirmed locally transmitted COVID-19 cases -- two each in Shenyang and Yingkou.
- Plan to boost eye care services by 2030
- China sees wider healthcare access as system continues to grow
- China moves to further improve family doctor services
- China targets better health for all by 2030
- China targets average life expectancy of 80 by 2030 in new five-year health plan
- The number of assisted reproductive institutions reaches 645 in China


